JAGUAR HEALTH, INC. Class of Warrant or Right, Outstanding
JAGUAR HEALTH, INC. (JAGX) had Class of Warrant or Right, Outstanding of 148.17 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-19
- 2026-06-30: Class of Warrant or Right, Outstanding 148.17K shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 278.74K shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 105.95K shares; Class of Warrant or Right, Outstanding as first filed 3.71M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 2.58M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 148.17K shares 10-Q · filed 2026-08-19 | |
| 2026-03-31 | 278.74K shares 10-Q · filed 2026-05-20 | |
| 2025-12-31 | 105.95K shares 10-Q · filed 2026-08-19 | 3.71M shares 10-K · filed 2026-04-07 |
| 2025-09-30 | 2.58M shares 10-Q · filed 2025-11-14 | |
| 2025-06-30 | 2.09M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 663.00K shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 87.00 shares 10-Q · filed 2026-08-19 | 3.04K shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 76.13K shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 76.20K shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 4.57M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 8.07K shares 10-K · filed 2026-04-07 | 11.42M shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 11.42M shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 10.67M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 7.50K shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 5.00 shares 10-K · filed 2025-03-31 | 7.50K shares 10-K · filed 2023-03-24 |
| 2022-09-30 | 562.85K shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 563.45K shares 10-Q · filed 2022-08-22 | |
| 2022-03-31 | 563.45K shares 10-Q · filed 2022-05-10 | |
| 2021-12-31 | 7.51K shares 10-K · filed 2024-04-01 | 563.45K shares 10-K · filed 2022-03-11 |
| 2021-09-30 | 563.45K shares 10-Q · filed 2021-11-17 | |
| 2021-06-30 | 1.69M shares 10-Q · filed 2021-08-13 | |
| 2021-03-31 | 1.59M shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 32.02K shares 10-K · filed 2023-03-24 | 7.21M shares 10-K · filed 2021-03-31 |
| 2020-09-30 | 7.34M shares 10-Q · filed 2020-11-16 | |
| 2020-06-30 | 16.99M shares 10-Q · filed 2020-08-13 | |
| 2020-03-31 | 17.62M shares 10-Q · filed 2020-05-15 | |
| 2019-12-31 | 6.47M shares 10-K · filed 2022-03-11 | 19.42M shares 10-Q · filed 2020-05-15 |
| 2019-09-30 | 19.42M shares 10-Q · filed 2019-11-14 | |
| 2019-06-30 | 1.24M shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 5.03M shares 10-Q · filed 2019-05-21 | |
| 2018-12-31 | 34.68K shares 10-K · filed 2021-03-31 | 2.43M shares 10-K · filed 2019-04-10 |
| 2018-09-30 | 16.58K shares 10-Q · filed 2019-11-14 | 1.16M shares 10-Q · filed 2018-11-19 |
| 2018-06-30 | 270.76K shares 10-Q · filed 2018-08-13 | |
| 2018-03-31 | 4.82M shares 10-Q · filed 2018-05-15 | |
| 2017-12-31 | 4.59K shares 10-Q · filed 2019-11-14 | 4.82M shares 10-K · filed 2018-04-09 |
| 2017-09-30 | 6.66M shares 10-Q · filed 2017-11-20 | |
| 2017-06-30 | 6.34M shares 10-Q · filed 2017-08-09 | |
| 2017-03-31 | 6.34M shares 10-Q/A · filed 2017-06-23 | |
| 2016-12-31 | 397.90K shares 10-K · filed 2019-04-10 | 5.97M shares 10-K · filed 2017-02-15 |
| 2016-09-30 | 715.54K shares 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 748.87K shares 10-Q · filed 2016-08-15 | |
| 2016-03-31 | 748.87K shares 10-Q · filed 2016-05-10 | |
| 2015-12-31 | 748.87K shares 10-K · filed 2018-04-09 | |
| 2015-09-30 | 748.87K shares 10-Q · filed 2016-11-14 | |
| 2015-06-30 | 748.87K shares 10-Q · filed 2016-08-15 | |
| 2015-03-31 | 605.87K shares 10-Q · filed 2016-05-10 | |
| 2014-12-31 | 494.27K shares 10-K · filed 2017-02-15 | |
| 2013-12-31 | 207.66K shares 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |